Student and Faculty Publications
Publication Date
8-18-2023
Journal
Cancers
Abstract
Imaging is essential for evaluating patients with glioblastoma. Traditionally a multimodality undertaking, CT, including CT cerebral blood profusion, PET/CT with traditional fluorine-18 fluorodeoxyglucose (18F-FDG), and MRI have been the mainstays for diagnosis and post-therapeutic assessment. However, recent advances in these modalities, in league with the emerging fields of radiomics and theranostics, may prove helpful in improving diagnostic accuracy and treating the disease.
Keywords
glioblastoma, GBM, glioma, high-grade glioma, CT, MRI, PET, theranostics, radiomics
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Oncology Commons, Radiation Medicine Commons, Radiology Commons
Comments
Data Availability Statement
PMID: 37627190